# OnCo record nct06984588 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06984588/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06984588", "NCT06984588" ;
  schema:name "A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer"@en ;
  schema:description "A phase 2/3 trial testing Uliledlimab in non-small-cell lung cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06984588/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06984588> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2024-03-28" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/uliledlimab/> ;
  onco:companies <https://onco.cc/companies/tj-biopharma/> .